DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM Jun 23, 2017
Preferred Dental Technologies Inc. announces it’s EAS product is being included in presentation Jun 23, 2017
Preferred Dental Technologies Inc. (the “Company”) (CSE: PDT): The Company Announces EAS Product Demonstration Jun 22, 2017
First Global Launches World’s First Social Messaging Remittance Service with LianLian Pay on the WeChat Platform from the USA Jun 21, 2017
